<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000413947">
  <TermName>gadolinium texaphyrin</TermName>
  <TermPronunciation>(GA-doh-LIH-nee-um tek-SA-fih-rin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment and diagnosis of some types of cancer. It builds up in some cancer cells, which may make them easier to kill with radiation therapy and chemotherapy. Gadolinium texaphyrin is also used in magnetic resonance imaging (MRI) to help find cancer cells in the body. It is a type of radiosensitizing agent, a type of chemosensitizing agent, and a type of contrast agent. Also called motexafin gadolinium.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713525" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gadolinium texaphyrin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713526" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gadolinio texapirina&quot;" language="es" id="_4"/>
  <SpanishTermName>gadolinio texapirina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Puede aumentar la sensibilidad de las células tumorales a la radioterapia, mejorar las imágenes del tumor con el uso de la imaginología por resonancia magnética (IRM) y destruir las células cancerosas. Es un tipo de complejo de metaloporfirina. También se llama gadolinio motexafina.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-05-23</DateFirstPublished>
  <DateLastModified>2013-04-01</DateLastModified>
</GlossaryTerm>
